New Altach Publication in European Cells and Materials (eCM)

Altach Biomedical is excited to announce the publication of a major preclinical study in European Cells and Materials, detailing a novel approach to single-stage cartilage repair using rapidly isolated progenitor cells in combination with Altach’s proprietary type II collagen scaffolds. The study, led by Altach Biomedical’s Chief Technology Officer Dr. David Browe alongside Altach co-founders Professor Daniel Kelly and Professor Conor Buckley of Trinity College Dublin, demonstrates that clinically relevant numbers of chondro-progenitor cells can be isolated from the infrapatellar fat pad in under one hour. These cells, when paired with Altach’s highly porous, chondro-permissive type II collagen scaffolds, promoted robust cartilage-like tissue formation in both in vitro and large animal models.

“This research showcases the potential of combining rapid intraoperative cell isolation with our next-generation collagen scaffold technology to create a cost-effective, single-stage solution for cartilage regeneration,” said Dr. Browe.

The findings mark a significant step toward scalable and efficient therapies for treating cartilage injuries and early-stage osteoarthritis. The study lays the groundwork for future clinical applications of Altach’s biomaterials platform in orthopaedic regenerative medicine.

The full publication is available at https://www.ecmjournal.org/papers/vol050/vol050a04.php